Are TCM Ltd latest results good or bad?

TCM Ltd's latest financial results for the quarter ended March 2026 reveal significant operational challenges. The company reported net sales of ₹4.92 crores, which represents a decline of 35.69% year-over-year from ₹7.65 crores in March 2025. This decline in revenue is compounded by a net loss of ₹1.65 crores, marking a substantial deterioration compared to the profit of ₹4.03 crores recorded in the same quarter last year, reflecting a negative growth of 140.94%. The operating margin, excluding other income, was reported at -23.78%, indicating a severe compression in profitability compared to -9.67% in the previous quarter. This marks the lowest operating margin in seven quarters, highlighting ongoing operational distress. The company has now faced six consecutive quarters of negative operating margins, raising concerns about its business model viability. Additionally, the financial metrics indicate rising employee costs, which surged by 27.43% sequentially, and a troubling cash flow situation, with negative operating cash flow reported at ₹10.00 crores for FY25. The balance sheet shows a deterioration in quality, with current liabilities exceeding current assets, resulting in negative working capital. Despite a recent stock price increase of 4.93%, TCM Ltd's fundamentals suggest a critical need for improvement in operational performance. The company saw an adjustment in its evaluation, reflecting the ongoing challenges it faces in generating sustainable profitability and managing cash flow effectively. Overall, the financial results underscore a company grappling with deep-seated structural issues and a lack of institutional investor confidence.